ASHLEY M MILLER ET AL: "The IL-33/ST2 pathway A new therapeutic target in cardiovascular disease", PHARMACOLOGY AND THERAPEUTICS, vol. 131, no. 2, 26 February 2011 (2011-02-26), pages 179-186, XP028233696, ISSN: 0163-7258, DOI: 10.1016/J.PHARMTHERA.2011.02.005 [retrieved on 2011-02-26] (B1)

WO-A2-2011/127412 (B1)

BARKSBY H E ET AL: "The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders", CLINICAL AND EXPERIMENTAL IMMUNOLOGY, WILEY-BLACKWELL PUBLISHING LTD, GB, vol. 149, no. 2, 1 August 2007 (2007-08-01), pages 217-225, XP002566163, ISSN: 0009-9104, DOI: 10.1111/J.1365-2249.2007.03441.X [retrieved on 2007-06-21] (B1)

Chuan Qiu ET AL: "Anti-interleukin-33 inhibits cigarette smoke-induced lung inflammation in mice", Immunology, vol. 138, no. 1, 13 January 2013 (2013-01-13), pages 76-82, XP055243811, GB ISSN: 0019-2805, DOI: 10.1111/imm.12020 (B1)

Douglas A. Plager ET AL: "Gene Transcription Changes in Asthmatic Chronic Rhinosinusitis with Nasal Polyps and Comparison to Those in Atopic Dermatitis", PLoS ONE, vol. 5, no. 7, 6 January 2010 (2010-01-06) , page e11450, XP055619903, DOI: 10.1371/journal.pone.0011450 (B1)

GABY PALMER ET AL: "Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis", ARTHRITIS & RHEUMATISM, vol. 60, no. 3, 1 March 2009 (2009-03-01), pages 738-749, XP055016952, ISSN: 0004-3591, DOI: 10.1002/art.24305 (B1)

KEISUKE OBOKI ET AL: "IL-33 and IL-33 Receptors in Host Defense and Diseases", ALLERGOLOGY INTERNATIONAL, vol. 59, no. 2, 1 June 2010 (2010-06-01), pages 143-160, XP055016757, ISSN: 1323-8930, DOI: 10.2332/allergolint.10-RAI-0186 (B1)

KUROIWA K ET AL: "CONSTRUCTION OF ELISA SYSTEM TO QUANTIFY HUMAN ST2 PROTEIN IN SERA OF PATIENTS", HYBRIDOMA, LIEBERT, NEW YORK, NY, US, vol. 19, no. 2, 1 January 2000 (2000-01-01), pages 151-159, XP008013066, ISSN: 0272-457X, DOI: 10.1089/02724570050031194 (B1)

Keisuke Oboki ET AL: "IL-33 and IL-33 Receptors in Host Defense and Diseases", Allergology International, vol. 59, no. 2, 1 June 2010 (2010-06-01), pages 143-160, XP055016756, ISSN: 1323-8930, DOI: 10.2332/allergolint.10-RAI-0186 (B1)

LEUNG BERNARD P ET AL: "A novel therapy of murine collagen-induced arthritis with soluble T1/ST2", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, INC, US, vol. 173, no. 1, 1 July 2004 (2004-07-01), pages 145-150, XP009167840, ISSN: 0022-1767, DOI: 10.4049/JIMMUNOL.173.1.145 (B1)

LI MINGCAI ET AL: "IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice", JOURNAL OF NEUROIMMUNOLOGY, vol. 247, no. 1-2, 15 June 2012 (2012-06-15), pages 25-31, ISSN: 0165-5728(print) (B1)

MANETTI MIRKO ET AL: "The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis", ANNALS OF THE RHEUMATIC DISEASES, BRITISH MEDICAL ASSOCIATION, GB, vol. 69, no. 3, 1 March 2010 (2010-03-01), pages 598-605, XP009167830, ISSN: 0003-4967, DOI: 10.1136/ARD.2009.119321 (B1)

SMITH D E: "IL-33: a tissue derived cytokine pathway involved in allergic inflammation and asthma", CLINICAL AND EXPERIMENTAL ALLERGY, vol. 40, no. 2, February 2010 (2010-02), pages 200-208, ISSN: 0954-7894(print) (B1)

US-A1- 2005 058 639 (B1)

US-A1- 2009 214 559 (B1)

US-A1- 2010 221 257 (B1)

US-A1- 2010 247 442 (B1)

US-A1- 2010 247 545 (B1)

US-A1- 2011 256 635 (B1)

US-A1- 2012 213 774 (B1)

Axel J. Hueber ET AL: "IL-33 induces skin inflammation with mast cell and neutrophil activation", European Journal of Immunology, vol. 41, no. 8, 1 August 2011 (2011-08-01) , pages 2229-2237, XP055016459, ISSN: 0014-2980, DOI: 10.1002/eji.201041360 (B1)